MMPW
LLY icon

Mitchell McLeod Pugh & Williams’s Eli Lilly LLY Stock Holding History

Mitchell McLeod Pugh & Williams’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.95M Buy
7,466
+1,242
+20% +$1.27M 1.1% 20
2026
Q1 		$5.72M Hold
6,224
– – 0.84% 24
2025
Q4 		$6.59M Buy
6,224
+990
+19% +$947K 0.94% 22
2025
Q3 		$4.29M Sell
5,234
-80
-2% -$59.5K 0.69% 27
2025
Q2 		$4.14M Buy
5,314
+140
+3% +$109K 0.77% 24
2025
Q1 		$4.27M Sell
5,174
-34
-0.7% -$28.3K 0.88% 23
2024
Q4 		$4.02M Sell
5,208
-1,191
-19% -$986K 0.84% 23
2024
Q3 		$5.67M Sell
6,399
-190
-3% -$171K 1.18% 16
2024
Q2 		$5.97M Sell
6,589
-169
-3% -$135K 1.36% 12
2024
Q1 		$5.26M Sell
6,758
-524
-7% -$373K 1.26% 14
2023
Q4 		$4.24M Buy
7,282
+60
+0.8% +$35K 1.12% 19
2023
Q3 		$3.88M Sell
7,222
-99
-1% -$51K 1.14% 19
2023
Q2 		$3.43M Sell
7,321
-130
-2% -$54.5K 0.99% 21
2023
Q1 		$2.56M Sell
7,451
-419
-5% -$141K 0.8% 25
2022
Q4 		$2.88M Sell
7,870
-158
-2% -$56K 0.97% 19
2022
Q3 		$2.6M Sell
8,028
-86
-1% -$27.2K 1% 21
2022
Q2 		$2.63M Sell
8,114
-455
-5% -$137K 1.02% 20
2022
Q1 		$2.45M Sell
8,569
-75
-0.9% -$19.3K 0.82% 27
2021
Q4 		$2.39M Sell
8,644
-375
-4% -$95.1K 0.79% 28
2021
Q3 		$2.08M Sell
9,019
-800
-8% -$197K 0.77% 28
2021
Q2 		$2.25M Buy
9,819
+200
+2% +$40.2K 0.87% 22
2021
Q1 		$1.8M Sell
9,619
-760
-7% -$149K 0.75% 30
2020
Q4 		$1.75M Hold
10,379
– – 0.8% 28
2020
Q3 		$1.54M Buy
10,379
+300
+3% +$46.4K 0.79% 29
2020
Q2 		$1.66M Buy
10,079
+1,470
+17% +$226K 0.94% 23
2020
Q1 		$1.19M Buy
8,609
+650
+8% +$89.3K 0.92% 25
2019
Q4 		$1.05M Sell
7,959
-23
-0.3% -$2.67K 0.66% 46
2019
Q3 		$893K Buy
7,982
+90
+1% +$10K 0.61% 58
2019
Q2 		$874K Sell
7,892
-105
-1% -$12.4K 0.6% 58
2019
Q1 		$1.04M Sell
7,997
-1,300
-14% -$158K 0.72% 39
2018
Q4 		$1.08M Buy
9,297
+180
+2% +$20.1K 0.86% 31
2018
Q3 		$978K Sell
9,117
-1,855
-17% -$185K 0.66% 46
2018
Q2 		$937K Sell
10,972
-160
-1% -$13.1K 0.66% 45
2018
Q1 		$861K Sell
11,132
-89
-0.8% -$7.17K 0.62% 52
2017
Q4 		$947K Buy
11,221
+89
+0.8% +$7.57K 0.65% 46
2017
Q3 		$953K Hold
11,132
– – 0.7% 46
2017
Q2 		$916K Sell
11,132
-98
-0.9% -$8K 0.7% 48
2017
Q1 		$944K Buy
11,230
+1
+0% +$80 0.74% 44
2016
Q4 		$826K Buy
11,229
+1
+0% +$74 0.67% 52
2016
Q3 		$901K Buy
11,228
+2
+0% +$160 0.79% 42
2016
Q2 		$884K Buy
11,226
+201
+2% +$15.1K 0.8% 44
2016
Q1 		$794K Hold
11,025
– – 0.77% 44
2015
Q4 		$929K Hold
11,025
– – 0.92% 35
2015
Q3 		$923K Hold
11,025
– – 0.95% 31
2015
Q2 		$920K Hold
11,025
– – 0.85% 38
2015
Q1 		$801K Hold
11,025
– – 0.73% 46
2014
Q4 		$761K Buy
+11,025
New +$744K 0.7% 48

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Mitchell McLeod Pugh & Williams's LLY Position: Q2 2026 in Review

Mitchell McLeod Pugh & Williams increased its Eli Lilly (LLY) stake by 20% in Q2 2026, buying an estimated $1.27M and bringing the position to 7,466 shares worth $8.95M. The position accounts for 1.1% of the portfolio, ranked #20.

Mitchell McLeod Pugh & Williams first reported a position in LLY in Q4 2014 and has held it in 47 quarters since. 4,602 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Mitchell McLeod Pugh & Williams held 7,466 shares of Eli Lilly worth $8.95M as of Q2 2026.
  • Mitchell McLeod Pugh & Williams bought 1,242 Eli Lilly shares in Q2 2026, an estimated $1.27M.
  • Eli Lilly made up 1.1% of Mitchell McLeod Pugh & Williams's portfolio in Q2 2026, its #20 holding.
  • Mitchell McLeod Pugh & Williams first reported a position in Eli Lilly in Q4 2014 and has held it in 47 quarters since.
  • 4,602 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Mitchell McLeod Pugh & Williams's 13F filing for Q2 2026, filed 11 Aug 2026.